sodium cromoglycate formulated as a pressurized aerosol ( 2 mg 4-times daily ) and placebo were compared in 31 adult asthmatic patients in a double-blind crossover trial lasting 12 weeks .
C0012694
sodium cromoglycate
C0004096
asthmatic